Early treatment of rheumatoid arthritis: Rationale, evidence, and implications

Annals of the Rheumatic Diseases

Volumn 57, Issue 9, 1998, Pages 511-512

  Van De Putte, L B A ^a   Van Gestel, A M ^a   Van Riel, P L C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ANTIRHEUMATIC AGENT; AURANOFIN; AZATHIOPRINE; CYCLOSPORIN; GOLD DERIVATIVE; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

CLINICAL TRIAL; DISEASE ACTIVITY; HUMAN; JOINT DESTRUCTION; LIFESPAN; MORTALITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; REMISSION; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0031690147     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.57.9.511     Document Type: Review

References (2)